Sun Pharma inches up on getting nod to raise up to Rs 10,000 crore via NCDs
Sun Pharmaceutical Industries is currently trading at Rs. 1759.90, up by 0.80 points or 0.05 % from its previous closing of Rs. 1759.10 on the BSE.
The scrip opened at Rs. 1762.30 and has touched a high and low of Rs. 1769.70 and Rs. 1751.50 respectively. So far 24868 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 2047.55 on 31-Jul-2026 and a 52 week low of Rs. 1583.60 on 29-Jan-2026.
Last one week high and low of the scrip stood at Rs. 1803.35 and Rs. 1744.95 respectively. The current market cap of the company is Rs. 422666.85 crore.
The promoters holding in the company stood at 54.48%, while Institutions and Non-Institutions held 36.70% and 8.82% respectively.
Sun Pharmaceutical Industries (Sun Pharma) has received approval for the issuance of listed, rated, unsecured, redeemable nonconvertible debentures (NCDs), on a private placement basis, in one or more tranches and/or series, for an aggregate amount not exceeding Rs 10,000 crore. The Board of Directors of the Company at its meeting held on October 12, 2026, has, inter alia, considered and approved the same.
.jpg)
